Unknown OBSERVATIONAL NCT05757804

Study of 18F-0502B PET Imaging Targeting α-synuclein in the Diagnosis of α-synuclein-related Diseases

Sponsor: Huashan Hospital

Conditions Alpha Synuclein Pathology Positron-Emission Tomography

Updated 4 times since 2023 Last updated: Mar 13, 2023 Started: Mar 17, 2023 Primary completion: Jul 15, 2023 Completion: Jan 14, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Alpha Synuclein Pathology and Positron-Emission Tomography and is currently ongoing. Huashan Hospital leads this study, which shows 4 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Apr 2025 — Present [monthly]

Unknown

Status: Recruiting → Unknown
Sep 2024 — Apr 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Apr 2023 — Jul 2024 [monthly]

Recruiting

First recorded

Mar 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Huashan Hospital

Data source: Huashan Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China